Literature DB >> 25270969

[High-resolution distortion-product otoacoustic emissions: method and clinical applications].

T Janssen1, A Lodwig, J Müller, H Oswald.   

Abstract

Unlike pure tone thresholds that assess both peripheral and central sound processing, distortion-product otoacoustic emissions (DPOAEs) selectively mirror the functioning of the cochlear amplifier. High resolution DPOAEs are missing in the toolbox of routine audiometry due to the fact that high resolution DPOAE measurements are more time-consuming when compared to normal clinical DP grams with rough frequency resolution. Measurements of high resolution DPOAEs allow an early assessment of beginning sensory cell damage due to sound overexposure or administration of ototoxic drugs. When using a rough grid, sensory cell damage would be overlooked as in the early state damage only appears at some distinct cochlear sites. A review is given on the method and application of high resolution DPOAEs.

Entities:  

Mesh:

Year:  2014        PMID: 25270969     DOI: 10.1007/s00106-014-2921-6

Source DB:  PubMed          Journal:  HNO        ISSN: 0017-6192            Impact factor:   1.284


  25 in total

1.  Impact of occupational noise on pure-tone threshold and distortion product otoacoustic emissions after one workday.

Authors:  Jörg Müller; Thomas Janssen
Journal:  Hear Res       Date:  2008-09-25       Impact factor: 3.208

Review 2.  Evoked otoacoustic emissions arise by two fundamentally different mechanisms: a taxonomy for mammalian OAEs.

Authors:  C A Shera; J J Guinan
Journal:  J Acoust Soc Am       Date:  1999-02       Impact factor: 1.840

3.  Fine structure of the 2 f1-f2 acoustic distortion products: effects of primary level and frequency ratios.

Authors:  N He; R A Schmiedt
Journal:  J Acoust Soc Am       Date:  1997-06       Impact factor: 1.840

4.  Two-source interference as the major reason for auditory-threshold estimation error based on DPOAE input-output functions in normal-hearing subjects.

Authors:  Ernst Dalhoff; Diana Turcanu; Aleš Vetešník; Anthony W Gummer
Journal:  Hear Res       Date:  2012-12-23       Impact factor: 3.208

5.  Evoked mechanical responses of isolated cochlear outer hair cells.

Authors:  W E Brownell; C R Bader; D Bertrand; Y de Ribaupierre
Journal:  Science       Date:  1985-01-11       Impact factor: 47.728

6.  Variation of distortion product otoacoustic emissions with furosemide injection.

Authors:  D M Mills; E W Rubel
Journal:  Hear Res       Date:  1994-06-15       Impact factor: 3.208

7.  Ototoxic impact of cisplatin in pediatric oncology patients.

Authors:  A L Berg; J B Spitzer; J H Garvin
Journal:  Laryngoscope       Date:  1999-11       Impact factor: 3.325

8.  Variability of noise-induced damage in the guinea pig cochlea: electrophysiological and morphological correlates after strictly controlled exposures.

Authors:  A R Cody; D Robertson
Journal:  Hear Res       Date:  1983-01       Impact factor: 3.208

9.  Otoacoustic emissions and quinine sulfate.

Authors:  D McFadden; E G Pasanen
Journal:  J Acoust Soc Am       Date:  1994-06       Impact factor: 1.840

10.  Ototoxicity of high-dose cisplatin by bolus administration in patients with advanced cancers and normal hearing.

Authors:  J Kopelman; A S Budnick; R B Sessions; M B Kramer; G Y Wong
Journal:  Laryngoscope       Date:  1988-08       Impact factor: 3.325

View more
  2 in total

1.  ADANO recommendations for the selection of target parameters and measurement processes for the use of auditory evoked potentials, otoacoustic emissions, and impedance audiometry in clinical trials : Prepared by the ERA consortium (AG-ERA)* of ADANO#. Confirmed by the board of ADANO on 18.01.2019.

Authors:  T Rahne; O Dziemba; A Lodwig; D Polterauer; R Thie; M Walger; T Wesarg; S Hoth
Journal:  HNO       Date:  2019-06       Impact factor: 1.284

Review 2.  S3 Guideline: Chronic Tinnitus : German Society for Otorhinolaryngology, Head and Neck Surgery e. V. (DGHNO-KHC).

Authors:  Birgit Mazurek; Gerhard Hesse; Heribert Sattel; Volker Kratzsch; Claas Lahmann; Christian Dobel
Journal:  HNO       Date:  2022-10-13       Impact factor: 1.330

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.